Employers Argue For Expansion Of Biosimilars To Help Lower Costs

By Ariel Cohen / April 1, 2020 at 12:40 PM

The ERISA Industry Committee released Tuesday (March 31) research findings of the potential savings to employers and employees from using more biosimilars.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.